|
시장보고서
상품코드
1873705
세계의 혈당 모니터링 시스템(BGMS) : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)BGMS (Blood Glucose Monitoring System) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
QYResearch
세계의 혈당 모니터링 시스템(BGMS) 시장 규모는 2024년에 165억 8,800만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 9.7%로 성장하여 2031년까지 320억 200만 달러로 확대될 것으로 예측됩니다.
혈당 모니터링 시스템이란, 특히 당뇨병 환자의 혈당를 측정하고 추적하기 위한 의료기기 또는 시스템입니다. 여기에는 테스트 스트립과 혈당 측정기를 사용하는 전통적인 자가 혈당 측정(SMBG) 기기 외에도 웨어러블 센서를 통해 실시간 데이터를 제공하는 첨단 연속 혈당 모니터링(CGM) 시스템이 포함됩니다. 이러한 시스템은 환자와 의료진이 혈당을 관리하고 약물을 조절하며 저혈당, 고혈당 등의 합병증을 예방할 수 있도록 도와줍니다.
혈당 모니터링 시스템 시장은 고령화, 운동 부족, 부적절한 식습관으로 인한 전 세계 당뇨병 환자 증가가 주요 촉진요인으로 작용하고 있습니다. 혈당 관리의 중요성에 대한 인식 증가, 의료비 증가, 만성 질환 관리에 대한 정부 지원과 함께 지속적 혈당 측정기(CGM)와 자가 혈당 측정기(SMBG)에 대한 수요를 증가시키고 있습니다. 스마트폰 연결, 실시간 알림, 비침습적 센서 등의 기술 발전은 특히 젊은 층과 기술에 정통한 환자층을 중심으로 시장을 더욱 확대시키고 있습니다.
수요는 견조한 반면, 시장에는 몇 가지 과제가 존재합니다. 특히 CGM과 첨단 디지털 플랫폼의 고가의 장비 비용은 중저소득 국가에서의 보급을 제한하고 있습니다. 또한, 사용자의 사용 준수 및 정확성에 대한 우려(특히 부적절한 기기 사용 및 교정 오류)는 임상 결과와 환자의 신뢰에 영향을 미칠 수 있습니다. 규제적 장벽, 상환 문제, 경쟁 시장에서의 차별화를 위한 지속적인 혁신의 필요성도 제조업체에게 중요한 장벽으로 작용하고 있습니다.
이 보고서는 혈당 측정 시스템(BGMS) 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
혈당 모니터링 시스템(BGMS) 시장 규모 추정 및 예측은 매출액 기준으로 제시되며, 2024년을 기준 연도로 하여 2020년부터 2031년까지의 기간의 과거 데이터와 예측 데이터를 포함합니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 혈당 모니터링 시스템(BGMS)에 대한 정보에 기반한 비즈니스 의사결정을 내릴 수 있도록 도와드립니다.
시장 세분화
기업별
- Abbott
- Roche
- Lifescan
- Ascensia
- ARKRAY
- Sinocare
- I-SENS
- Terumo
- B. Braun
- Acon
- Yicheng
- Omron
- SD Biosensor
- 77 Elektronika
- Yuwell
- Osang Healthcare
- AgaMatrix
- Senseonics Holdings
- Sinomedisite
- Vivacheck
- Empecs
- Andon
- Dexcom
- Medtronic
- Meiqi Medical
- Medtrum Technologies
- MicroTech Medical
유형별 부문
- 혈당 측정용 테스트 스트립
- 혈당 측정기
- CGM
용도별 부문
- 병원
- 가정용
지역별
- 북미
- 미국
- 캐나다
- 아시아태평양
- 중국
- 일본
- 한국
- 동남아시아
- 인도
- 호주
- 기타 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 네덜란드
- 북유럽 국가
- 기타 유럽
- 라틴아메리카
- 멕시코
- 브라질
- 기타 라틴아메리카
- 중동 및 아프리카
- 튀르키예
- 사우디아라비아
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
자주 묻는 질문
The global market for BGMS (Blood Glucose Monitoring System) was estimated to be worth US$ 16588 million in 2024 and is forecast to a readjusted size of US$ 32002 million by 2031 with a CAGR of 9.7% during the forecast period 2025-2031.
A blood glucose monitoring system is a medical device or system used to measure and track blood glucose (sugar) levels in individuals, especially those with diabetes. It includes traditional self-monitoring blood glucose (SMBG) devices using test strips and glucometers, as well as advanced continuous glucose monitoring (CGM) systems that provide real-time data through wearable sensors. These systems help patients and healthcare providers manage blood sugar levels, adjust medications, and prevent complications like hypoglycemia or hyperglycemia.
The blood glucose monitoring system market is primarily driven by the global rise in diabetes prevalence, fueled by aging populations, sedentary lifestyles, and poor dietary habits. Growing awareness of the importance of glucose control, along with increased healthcare spending and government support for chronic disease management, is boosting demand for both continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) devices. Technological advancements such as smartphone connectivity, real-time alerts, and non-invasive sensors are further expanding the market, especially among younger and tech-savvy patients.
Despite strong demand, the market faces several challenges. High device costs, especially for CGMs and advanced digital platforms, limit access in low- and middle-income countries. In addition, user adherence and accuracy concerns-particularly with improper device usage or calibration errors-can impact clinical outcomes and patient trust. Regulatory hurdles, reimbursement issues, and the need for continuous innovation to differentiate in a competitive market also pose significant obstacles for manufacturers.
This report aims to provide a comprehensive presentation of the global market for BGMS (Blood Glucose Monitoring System), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of BGMS (Blood Glucose Monitoring System) by region & country, by Type, and by Application.
The BGMS (Blood Glucose Monitoring System) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BGMS (Blood Glucose Monitoring System).
Market Segmentation
By Company
- Abbott
- Roche
- Lifescan
- Ascensia
- ARKRAY
- Sinocare
- I-SENS
- Terumo
- B. Braun
- Acon
- Yicheng
- Omron
- SD Biosensor
- 77 Elektronika
- Yuwell
- Osang Healthcare
- AgaMatrix
- Senseonics Holdings
- Sinomedisite
- Vivacheck
- Empecs
- Andon
- Dexcom
- Medtronic
- Meiqi Medical
- Medtrum Technologies
- MicroTech Medical
Segment by Type
- Blood Glucose Test Strips
- Blood Glucose Meter
- CGM
Segment by Application
- Hospital
- Household
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of BGMS (Blood Glucose Monitoring System) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of BGMS (Blood Glucose Monitoring System) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of BGMS (Blood Glucose Monitoring System) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 BGMS (Blood Glucose Monitoring System) Product Introduction
- 1.2 Global BGMS (Blood Glucose Monitoring System) Market Size Forecast (2020-2031)
- 1.3 BGMS (Blood Glucose Monitoring System) Market Trends & Drivers
- 1.3.1 BGMS (Blood Glucose Monitoring System) Industry Trends
- 1.3.2 BGMS (Blood Glucose Monitoring System) Market Drivers & Opportunity
- 1.3.3 BGMS (Blood Glucose Monitoring System) Market Challenges
- 1.3.4 BGMS (Blood Glucose Monitoring System) Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global BGMS (Blood Glucose Monitoring System) Players Revenue Ranking (2024)
- 2.2 Global BGMS (Blood Glucose Monitoring System) Revenue by Company (2020-2025)
- 2.3 Key Companies BGMS (Blood Glucose Monitoring System) Manufacturing Base Distribution and Headquarters
- 2.4 Key Companies BGMS (Blood Glucose Monitoring System) Product Offered
- 2.5 Key Companies Time to Begin Mass Production of BGMS (Blood Glucose Monitoring System)
- 2.6 BGMS (Blood Glucose Monitoring System) Market Competitive Analysis
- 2.6.1 BGMS (Blood Glucose Monitoring System) Market Concentration Rate (2020-2025)
- 2.6.2 Global 5 and 10 Largest Companies by BGMS (Blood Glucose Monitoring System) Revenue in 2024
- 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BGMS (Blood Glucose Monitoring System) as of 2024)
- 2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Blood Glucose Test Strips
- 3.1.2 Blood Glucose Meter
- 3.1.3 CGM
- 3.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type
- 3.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (2020-2031)
- 3.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Hospital
- 4.1.2 Household
- 4.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application
- 4.2.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (2020-2031)
- 4.2.3 Global BGMS (Blood Glucose Monitoring System) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
- 5.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region
- 5.1.1 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2020-2025)
- 5.1.3 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (2026-2031)
- 5.1.4 Global BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), (2020-2031)
- 5.2 North America
- 5.2.1 North America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.2.2 North America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.3 Europe
- 5.3.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.3.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.4.2 Asia Pacific BGMS (Blood Glucose Monitoring System) Sales Value by Region (%), 2024 VS 2031
- 5.5 South America
- 5.5.1 South America BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.5.2 South America BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
- 5.6 Middle East & Africa
- 5.6.1 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 5.6.2 Middle East & Africa BGMS (Blood Glucose Monitoring System) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.3 United States
- 6.3.1 United States BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.3.2 United States BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.4.2 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.5.2 China BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.6.2 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.7.2 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.8.2 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India BGMS (Blood Glucose Monitoring System) Sales Value, 2020-2031
- 6.9.2 India BGMS (Blood Glucose Monitoring System) Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India BGMS (Blood Glucose Monitoring System) Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Abbott
- 7.1.1 Abbott Profile
- 7.1.2 Abbott Main Business
- 7.1.3 Abbott BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.1.4 Abbott BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.1.5 Abbott Recent Developments
- 7.2 Roche
- 7.2.1 Roche Profile
- 7.2.2 Roche Main Business
- 7.2.3 Roche BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.2.4 Roche BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.2.5 Roche Recent Developments
- 7.3 Lifescan
- 7.3.1 Lifescan Profile
- 7.3.2 Lifescan Main Business
- 7.3.3 Lifescan BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.3.4 Lifescan BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.3.5 Lifescan Recent Developments
- 7.4 Ascensia
- 7.4.1 Ascensia Profile
- 7.4.2 Ascensia Main Business
- 7.4.3 Ascensia BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.4.4 Ascensia BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.4.5 Ascensia Recent Developments
- 7.5 ARKRAY
- 7.5.1 ARKRAY Profile
- 7.5.2 ARKRAY Main Business
- 7.5.3 ARKRAY BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.5.4 ARKRAY BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.5.5 ARKRAY Recent Developments
- 7.6 Sinocare
- 7.6.1 Sinocare Profile
- 7.6.2 Sinocare Main Business
- 7.6.3 Sinocare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.6.4 Sinocare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.6.5 Sinocare Recent Developments
- 7.7 I-SENS
- 7.7.1 I-SENS Profile
- 7.7.2 I-SENS Main Business
- 7.7.3 I-SENS BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.7.4 I-SENS BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.7.5 I-SENS Recent Developments
- 7.8 Terumo
- 7.8.1 Terumo Profile
- 7.8.2 Terumo Main Business
- 7.8.3 Terumo BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.8.4 Terumo BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.8.5 Terumo Recent Developments
- 7.9 B. Braun
- 7.9.1 B. Braun Profile
- 7.9.2 B. Braun Main Business
- 7.9.3 B. Braun BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.9.4 B. Braun BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.9.5 B. Braun Recent Developments
- 7.10 Acon
- 7.10.1 Acon Profile
- 7.10.2 Acon Main Business
- 7.10.3 Acon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.10.4 Acon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.10.5 Acon Recent Developments
- 7.11 Yicheng
- 7.11.1 Yicheng Profile
- 7.11.2 Yicheng Main Business
- 7.11.3 Yicheng BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.11.4 Yicheng BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.11.5 Yicheng Recent Developments
- 7.12 Omron
- 7.12.1 Omron Profile
- 7.12.2 Omron Main Business
- 7.12.3 Omron BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.12.4 Omron BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.12.5 Omron Recent Developments
- 7.13 SD Biosensor
- 7.13.1 SD Biosensor Profile
- 7.13.2 SD Biosensor Main Business
- 7.13.3 SD Biosensor BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.13.4 SD Biosensor BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.13.5 SD Biosensor Recent Developments
- 7.14 11 Elektronika
- 7.14.1 12 Elektronika Profile
- 7.14.2 14 Elektronika Main Business
- 7.14.3 16 Elektronika BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.14.4 18 Elektronika BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.14.5 19 Elektronika Recent Developments
- 7.15 Yuwell
- 7.15.1 Yuwell Profile
- 7.15.2 Yuwell Main Business
- 7.15.3 Yuwell BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.15.4 Yuwell BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.15.5 Yuwell Recent Developments
- 7.16 Osang Healthcare
- 7.16.1 Osang Healthcare Profile
- 7.16.2 Osang Healthcare Main Business
- 7.16.3 Osang Healthcare BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.16.4 Osang Healthcare BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.16.5 Osang Healthcare Recent Developments
- 7.17 AgaMatrix
- 7.17.1 AgaMatrix Profile
- 7.17.2 AgaMatrix Main Business
- 7.17.3 AgaMatrix BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.17.4 AgaMatrix BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.17.5 AgaMatrix Recent Developments
- 7.18 Senseonics Holdings
- 7.18.1 Senseonics Holdings Profile
- 7.18.2 Senseonics Holdings Main Business
- 7.18.3 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.18.4 Senseonics Holdings BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.18.5 Senseonics Holdings Recent Developments
- 7.19 Sinomedisite
- 7.19.1 Sinomedisite Profile
- 7.19.2 Sinomedisite Main Business
- 7.19.3 Sinomedisite BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.19.4 Sinomedisite BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.19.5 Sinomedisite Recent Developments
- 7.20 Vivacheck
- 7.20.1 Vivacheck Profile
- 7.20.2 Vivacheck Main Business
- 7.20.3 Vivacheck BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.20.4 Vivacheck BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.20.5 Vivacheck Recent Developments
- 7.21 Empecs
- 7.21.1 Empecs Profile
- 7.21.2 Empecs Main Business
- 7.21.3 Empecs BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.21.4 Empecs BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.21.5 Empecs Recent Developments
- 7.22 Andon
- 7.22.1 Andon Profile
- 7.22.2 Andon Main Business
- 7.22.3 Andon BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.22.4 Andon BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.22.5 Andon Recent Developments
- 7.23 Dexcom
- 7.23.1 Dexcom Profile
- 7.23.2 Dexcom Main Business
- 7.23.3 Dexcom BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.23.4 Dexcom BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.23.5 Dexcom Recent Developments
- 7.24 Medtronic
- 7.24.1 Medtronic Profile
- 7.24.2 Medtronic Main Business
- 7.24.3 Medtronic BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.24.4 Medtronic BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.24.5 Medtronic Recent Developments
- 7.25 Meiqi Medical
- 7.25.1 Meiqi Medical Profile
- 7.25.2 Meiqi Medical Main Business
- 7.25.3 Meiqi Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.25.4 Meiqi Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.25.5 Meiqi Medical Recent Developments
- 7.26 Medtrum Technologies
- 7.26.1 Medtrum Technologies Profile
- 7.26.2 Medtrum Technologies Main Business
- 7.26.3 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.26.4 Medtrum Technologies BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.26.5 Medtrum Technologies Recent Developments
- 7.27 MicroTech Medical
- 7.27.1 MicroTech Medical Profile
- 7.27.2 MicroTech Medical Main Business
- 7.27.3 MicroTech Medical BGMS (Blood Glucose Monitoring System) Products, Services and Solutions
- 7.27.4 MicroTech Medical BGMS (Blood Glucose Monitoring System) Revenue (US$ Million) & (2020-2025)
- 7.27.5 MicroTech Medical Recent Developments
8 Industry Chain Analysis
- 8.1 BGMS (Blood Glucose Monitoring System) Industrial Chain
- 8.2 BGMS (Blood Glucose Monitoring System) Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 BGMS (Blood Glucose Monitoring System) Sales Model
- 8.5.2 Sales Channel
- 8.5.3 BGMS (Blood Glucose Monitoring System) Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
